So They Say

Something looks very wrong with the management of the President's Star Wars missile defense program. Instead of clear and steady progress toward establishing its technological feasibility, the program's managers seem to shift emphasis every few months from one vaunted breakthrough to another. Last year the free-electron laser was hot stuff; now attention veers to crash development of space-based rockets. The primary goal seems political: getting production lines running before President Reagan l

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

More money for scientific and technological discoveries simply assisted other countries to exploit them, Sir Douglas told British Telecom managers. Most British scientists, particularly academic scientists, suffered from a British Empire syndrome.

"They argue that if research in any field of science and technology is being carried out anywhere in the world then it should be financed in Britain too," he said.

Instead of spreading research money too thinly, Britain should be monitoring . . . findings in other countries, particularly the United States and Japan, he said. Together with research on improving innovation, that would be better value for money.

I am afraid that it indicates a continued chemical approach to agriculture rather than a biological approach. Once things start this way, it's hard to stop....

"We are raising questions about the environmental risks and the fact that not much assessment of the industry is going on. But biotechnology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies